Insider Analysis From Sidley Austin LLP: Revised Drug GMP Regulations Significantly Raise Standards in China
This article was originally published in PharmAsia News
Executive Summary
By Lei Li, Sidley Austin LL
You may also be interested in...
China State FDA Reforms Expected, But When?
China's State FDA insists it will align the country's pharmaceutical and medical device regulations with international standards. The question on manufacturers' minds is, how soon
China State FDA Reforms Expected, But When?
China's State FDA insists it will align the country's pharmaceutical and medical device regulations with international standards. The question on manufacturers' minds is, how soon
SFDA Issues Revised GMP Draft Guideline Following Industry Comments; Expects Compliance To Come In Stages
SHANGHAI - Following industry comments, China's State FDA released another draft GMP guideline for which it seeks additional public comments. The revised draft offers clarity on a few key points but still leaves huge gaps that will need to be filled slowly over time